Table 2

Healthcare costs over 2 years of follow-up in the Tapering strategies in Rheumatoid Arthritis study according to intention to treat

Tapering csDMARDs first (n=94)Tapering TNF-inhibitor first (n=95)
Number of visits, mean (SD)Mean costs (SD)Number of visits, mean (SD)Mean costs (SD)
Medication*
 csDMARDs*€436 (€87)€972 (€123)
 TNF-inhibitor*€19 417 (€738)€9673 (€863)
 Prednisone€2.46 (€0.54)€2.84 (€0.59)
Medical consumption
 Hospitalisation13 ‡€326 (€1313)15 ‡€558 (€2271)
Standard healthcare
 Primary care physician7.7 (9)€260 (€302)8.9 (9)€303 (€318)
 Specialist12.0 (6)€1153 (€647)12 (6)€1203 (€738)
 Psychologist0.5 (2)€18 (€83)1.2 (8)€40 (€266)
Paramedical care
 Physical therapy14.4 (32)€506 (€1110)15.9 (31)€554 (€1063)
 Dietitian0.46 (2)€14 (€62)0.040 (0.3)€1.31 (€8.95)
 Social worker0.14 (0.6)€9.40 (€41)0.20 (0.8)€14 (€52)
 Speech therapist0.04 (0.3)€1.32 (€10)0.02 (0.2)€0.65 (€6.36)
Complementary medicine
 Homeopathy0.83 (3)€26 (€97)0.44 (2)€14 (€67)
Total healthcare costs, mean (SD)€22 484 (€8069)€13 616 (€9162)
  • *p<0.001 (linear regression adjusted for stratified randomisation).

  • †Number reflects the number of patients who got hospitalised within the 2 years of follow-up.

  • csDMARDs, conventional synthetic disease modifying antirheumatic drugs; ; TNF, tumour necrosis factor.